Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Breast Cancer Research and Treatment
|
July 28, 2011
Gene expression profiling of breast tumor cell lines to predict for therapeutic response to microtubule-stabilizing agents
Gais Kadra, Pascal Finetti, Yves Toiron, et al.
Expert Review of Proteomics
|
November 5, 2016
How may targeted proteomics complement genomic data in breast cancer?
Mathilde Guerin, Anthony Gonçalves, Yves Toiron, et al.
Genes, Chromosomes & Cancer
|
September 28, 2002
Molecular cytogenetics of the acute promyelocytic leukemia-derived cell line NB4 and of four all-trans retinoic acid-resistant subclones
Marie-Joëlle Mozziconacci, Angelika Rosenauer, Audrey Restouin, et al.
Oncotarget
|
September 24, 2016
Circulating vascular endothelial growth factor (VEGF) as predictive factor of progression-free survival in patients with advanced chordoma receiving sorafenib: an analysis from a phase II trial of the french sarcoma group (GSF/GETO)
Loic Lebellec, François Bertucci, Emmanuelle Tresch-Bruneel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 22, 2013
The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expression
Marion A Salvador, Julien Wicinski, Olivier Cabaud, et al.
The American Journal of Pathology
|
October 9, 2002
Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers
Christophe Ginestier, Emmanuelle Charafe-Jauffret, François Bertucci, et al.
Plos One
|
August 22, 2014
Poly(ADP-ribose) polymerase 1 (PARP1) overexpression in human breast cancer stem cells and resistance to olaparib
Marine Gilabert, Simon Launay, Christophe Ginestier, et al.
Molecular & Cellular Proteomics : MCP
|
April 23, 2008
Protein profiling of human breast tumor cells identifies novel biomarkers associated with molecular subtypes
Anthony Gonçalves, Emmanuelle Charafe-Jauffret, François Bertucci, et al.
BMC Cancer
|
October 12, 2018
Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial
Loïc Lebellec, François Bertucci, Emmanuelle Tresch-Bruneel, et al.
Oncotarget
|
October 19, 2018
Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer
Mathilde Guerin, Anthony Gonçalves, Yves Toiron, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Breast Cancer Research and Treatment
|
July 28, 2011
Gene expression profiling of breast tumor cell lines to predict for therapeutic response to microtubule-stabilizing agents
Gais Kadra, Pascal Finetti, Yves Toiron, et al.
Expert Review of Proteomics
|
November 5, 2016
How may targeted proteomics complement genomic data in breast cancer?
Mathilde Guerin, Anthony Gonçalves, Yves Toiron, et al.
Genes, Chromosomes & Cancer
|
September 28, 2002
Molecular cytogenetics of the acute promyelocytic leukemia-derived cell line NB4 and of four all-trans retinoic acid-resistant subclones
Marie-Joëlle Mozziconacci, Angelika Rosenauer, Audrey Restouin, et al.
Oncotarget
|
September 24, 2016
Circulating vascular endothelial growth factor (VEGF) as predictive factor of progression-free survival in patients with advanced chordoma receiving sorafenib: an analysis from a phase II trial of the french sarcoma group (GSF/GETO)
Loic Lebellec, François Bertucci, Emmanuelle Tresch-Bruneel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 22, 2013
The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expression
Marion A Salvador, Julien Wicinski, Olivier Cabaud, et al.
The American Journal of Pathology
|
October 9, 2002
Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers
Christophe Ginestier, Emmanuelle Charafe-Jauffret, François Bertucci, et al.
Plos One
|
August 22, 2014
Poly(ADP-ribose) polymerase 1 (PARP1) overexpression in human breast cancer stem cells and resistance to olaparib
Marine Gilabert, Simon Launay, Christophe Ginestier, et al.
Molecular & Cellular Proteomics : MCP
|
April 23, 2008
Protein profiling of human breast tumor cells identifies novel biomarkers associated with molecular subtypes
Anthony Gonçalves, Emmanuelle Charafe-Jauffret, François Bertucci, et al.
BMC Cancer
|
October 12, 2018
Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial
Loïc Lebellec, François Bertucci, Emmanuelle Tresch-Bruneel, et al.
Oncotarget
|
October 19, 2018
Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer
Mathilde Guerin, Anthony Gonçalves, Yves Toiron, et al.
Page
of 2